Clinical Implementation of Dual-energy CT for Proton Treatment Planning on Pseudo-monoenergetic CT scans.

PURPOSE: To determine whether a standardized clinical application of dual-energy computed tomography (DECT) for proton treatment planning based on pseudomonoenergetic CT scans (MonoCTs) is feasible and increases the precision of proton therapy in comparison with single-energy CT (SECT). METHODS AND MATERIALS: To define an optimized DECT protocol, CT scan settings were analyzed experimentally concerning beam hardening, image quality, and influence on the heuristic conversion of CT numbers into stopping-power ratios (SPRs) and were compared with SECT scans with identical CT dose. Differences in range prediction and dose distribution between SECT and MonoCT were quantified for phantoms and a patient. RESULTS: Dose distributions planned on SECT and MonoCT datasets revealed mean range deviations of 0.3 mm, γ passing rates (1%, 1 mm) greater than 99.9%, and no clinically relevant changes in dose-volume histograms. However, image noise and CT-related uncertainties could be reduced by MonoCT compared with SECT, which resulted in a slightly decreased dependence of SPR prediction on beam hardening. Consequently, DECT was clinically implemented at the University Proton Therapy Dresden in 2015. Until October 2016, 150 patients were treated based on MonoCTs, and more than 950 DECT scans of 351 patients were acquired during radiation therapy. CONCLUSIONS: A standardized clinical use of MonoCT for treatment planning is feasible, leads to improved image quality and SPR prediction, extends diagnostic variety, and enables a stepwise clinical implementation of DECT toward a physics-based, patient-specific, nonheuristic SPR determination. Further reductions of CT-related uncertainties, as expected from such SPR approaches, can be evaluated on the resulting DECT patient database.

A ³¹P-magnet resonance spectroscopy study on the metabolism of human masseter in individuals with different vertical facial pattern.

OBJECTIVE: The objective of this study was to investigate differences in masseter metabolism by (31)P-Chemical Shift Imaging (CSI) in adult individuals with different vertical facial patterns. The clinical study should be supported by functional findings at the mRNA level after orthognathic surgery. STUDY DESIGN: Twenty-two male volunteers (mean age 24.6) were divided into a deep-bite (NL/ML 11.8 ± 2.3°) and open-bite group (NL/ML 34.1 ± 2.6°). Vertical jaw relationship, gonial angle, and masseter volume were defined and compared with the phosphate values obtained from the (31)P spectra. Student t test and regression analysis were used. RESULTS: Phosphocreatine related strongly to muscle volume (P < .001), gonial angle (P < .001), and ML/NL angle (P < .01). Pi was found to be related to gonial angle (P < .05). Muscle volume was found to be inversely related to ML/NL (P < .01) and to the gonial angle (P < .01). CONCLUSIONS: A difference in masseter muscle metabolism between long- and short-faced subjects was confirmed at rest position.

Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.

It is obvious that FDG-PET has added value to CT, but there is still insufficient data to define the role of FDG-PET/CT in clinical practice. Usually data are gathered from multiple sources and in consequence the information obtained is heterogeneous and not always comparable between patients. To alleviate this lack of data, we attempted to investigate the differences in staging and therapeutic intent as compared with conventional staging in non small cell lung cancer (NSCLC) patients scheduled for RT after adding FDG-PET/CT to conventional staging in 104 included subjects. In contrary to the multicentric studies relying on patients medical records from outside institutions, these data were generated entirely with the institution's PET/CT unit. Significant modifications of both, M-stage and clinical stage were detected after inclusion of FDG-PET/CT data (p<0.001), while there was no statistically significant T- and N-stage modification. Overall implenting FDG-PET/CT revised RT intention decision in 34% of patients. FDG-PET/CT provides enhanced staging capabilities compared to conventional CT in staging of non small cell lung carcinoma and allows improved selection of patients suitable for curative intention, while avoiding unnecessary irradiation and costs in patients eligible to palliative intention.

Bone density of the midpalatal suture 7 months after surgically assisted rapid palatal expansion in adults.

INTRODUCTION: The aims of this study were to analyze changes in bone density of the midpalatal suture after surgically assisted rapid palatal expansion (SARPE) with the bone-borne Dresden Distractor (DD; ITU, Dresden, Germany) via computed tomography (CT) and to compare of preoperative surgical findings with a control group. METHODS: Sixteen adult patients (mean age 24.5 years) underwent axial CT scans before and 7 months after SARPE. CT image fusion was performed for the midpalatal suture bone. Sixty-six controls (mean age 25.7 years) served for comparing age-related bone density. Bone structure and density were assessed in the coronal plane at the anterior, median, and posterior levels. RESULTS: Highest density was found in the posterior part (1046 Hounsfield units [HU]) before expansion. Seven months after SARPE, bone density was 48% (anterior), 53% (median), and 75% (posterior) compared with preoperative values. The control group showed fairly equal Hounsfield units (889 HU to 900 HU) in all parts. CONCLUSIONS: Seven months after SARPE, the midpalatal suture's density achieves just one half to three quarters of the pretreatment values. To maintain the resistance against forces from the unsplit posterior part, the retention time should be lengthened.

Comment on "Developing DCE-CT to quantify intra-tumor heterogeneity in breast tumors with differing angiogenic phenotype".

In our comment some essential issues concerning determination of arterial input function (AIF), cardiac and respiratory related motion artifacts, contrast agent application and compartmental model fitting done by Cao et al., 2009 are discussed.

Dose reduction in computed tomography: the effect of eye and testicle shielding on radiation dose measured in patients with beryllium oxide-based optically stimulated luminescence dosimetry.

The aim of this study was to assess the effect of eye and testicle shielding on radiation dose to the lens and the testes of patients undergoing CT examinations. Fifty-one male patients underwent CT twice with identical protocols initially without, the second time with protective garments. Doses to the testes and the lenses were recorded with beryllium oxide-based dosimeters. The dose to the testes and lenses from CT exposure was reduced by 96.2% +/- 1.7% and 28.2% +/- 18.5%, when testicle and eye shielding was used, respectively. The effect of the eye shielding on the eye lens dose was found to depend on the x-ray tube position when the eye is primarily exposed during the scan. The maximum eye lens dose reduction achieved was found to be 43.2% +/- 6.5% corresponding to the anterior position of the tube. A significant correlation between the patient's body mass index and dose exposure could not be found. Eye and testicle shields, apart from being inexpensive and easy to use, were proven to be effective in reducing eye lens and testicle radiation dose burden from CT exposures.

MR perfusion measurements on pharyngeal tumors: comparison of quantification strategies.

For the case of pharyngeal carcinomas, the clinical value as well as the stability of several evaluation methods of MR tomographic perfusion measurement are compared. Eighteen patients suffering from histologically proven squamous cell carcinomas were investigated by MR tomography (1.5 T, 0.2 mmol/kg Gd-DTPA) prior to and during radiation therapy. Perfusion measurements were performed using a double-echo FLASH sequence. Parameters describing regional blood flow, blood volume, mean transit time, and interstitial concentration of contrast medium (CM) were calculated, applying seven different combinations of correction approaches (separating the shortening of T1 and T2*, arterial input function (AIF), and tumor shunts). Their correlations to MR independent tumor physiological parameters were analyzed (metabolic activity measurements using 18F-FDG-PET, polarographical pO2 measurement, tumor volume). Significant improvements of the correlation between perfusion-dependent and other tumor physiological parameters could be achieved by decoupling the shortening of T1 and T2* and by applying of the tumor shunt model. Deconvolution from the AIF deteriorated the correlation. Therefore, the elimination of the T1 shortening due to interstitial CM proves to be essential for MR perfusion measurements on contrast medium uptaking lesions. Depending on the measurement conditions (temporal resolution, signal-to-noise ratio), the consideration of the AIF can even make the results significantly worse by introducing additional measuring errors.